The role of inflammation in myocardial infarction

F. Crea (Roma, Italy)

Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Number: 8

PDF journal article, handout or slidesSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Crea (Roma, Italy). The role of inflammation in myocardial infarction. Research Seminar 2006 - Complexity of patients with multiple chronic diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How do antigen presenting cells see pathogens and cells?
Source: Annual Congress 2006 - Targeting innate immunity in respiratory diseases
Year: 2006


Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Source: Eur Respir J 2008; 31: 1334-1356
Year: 2008



Osteoporosis and inflammation
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



COPD: inflammatory mechanisms and systemic consequences
Source: Eur Respir Mon 2013; 59: 13-27
Year: 2013


PAH and inflammation: its role in pathogenesis - is it of value to modulate it?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005

Do antimicrobial peptides shape the adaptive immune response?
Source: Annual Congress 2005 - Interaction between innate and adaptive immunity in lung disease
Year: 2005

Chemokines, innate and adaptive immunity, and respiratory disease
Source: Eur Respir J 2002; 19: 350-355
Year: 2002



The new CF: a multisystem disorder
Source: Annual Congress 2007 - PG4 - Paediatric respiratory medicine: cystic fibrosis – the basics
Year: 2007



Autoimmunity and pulmonary hypertension: a perspective
Source: Eur Respir J 2005; 26: 1110-1118
Year: 2005



The future of targeted therapies for sarcoidosis
Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis
Year: 2005

The adaptive immune system, autoimmunity and COPD: lessons from human studies
Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Year: 2007


The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005

C-kit+ cell recruitment in remodelled pulmonary arteries of human PAH
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007



The role of viral and bacterial infections in asthma severity
Source: Annual Congress 2005 - PG3 - Asthma: natural history, risk factors and overall management
Year: 2005

The role of inflammation in cachexia
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Role of anti-proliferative therapy in PAH
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008


Lymphoid follicles in (very) severe COPD: beneficial or harmful?
Source: Eur Respir J 2009; 34: 219-230
Year: 2009



Activated lymphoid follicles, sign of an immune response, are present in early idiopathic pulmonary fibrosis (IPF) and increase with disease progression.
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021